Green Tech Co. Helps Ranchers Turn Manure Into Money
Source: Streetwise Reports  (8/24/22)
Bion Environmental Technologies Inc. is transforming cattle manure into natural gas, organic fertilizer, and clean water, and helping ranchers grow sustainable organic beef. More >

First Data Due by Year End 2022 From Study of New HAE Drug
Source: Hartaj Singh  (8/24/22)
Management's ongoing execution is raising the biopharma's profile among investors, noted an Oppenheimer report. More >

Mining Co. Reports More Positive Drill Results in Spain
Source: Adam Schatzker  (8/24/22)
New data thus far from drilling the deposit suggest the future resource grade will exceed the historical one, noted a Research Capital Corp. report. More >

New Chemical Assays from U3O8 Asset Notable
Source: Adam Schatzker   (8/24/22)
These results confirm the owner of this Athabasca Basin project identified a shallow uranium deposit with economic potential there, noted a Research Capital Corp. report. More >

New Schizophrenia Drug Has Chance of Getting FDA Approved
Source: Dr. Thomas Shrader   (8/24/22)
The U.S. Food and Drug Administration's follow-up to the new drug application for this potential treatment suggests a possible green light based on unmet medical need, noted a BTIG report. More >

GCM Mining, Have Your Gold and High Dividends Too
Source: Ron Struthers  (8/24/22)
Historically, dividends make up about 50% of stock market returns, so they are important. Not often can you find a solid, growing gold company with stellar management that is also offering over a 5% dividend yield. Expert Ron Struthers reviews the latest updates in gold stocks as well as GCM Mining Corp. More >

Explorer Creating District-Scale Yukon Gold Project
Source: Streetwise Reports  (8/24/22)
Shares of Snowline Gold Corp. traded to a new 52-week intraday high after the company posted initial assay results from its Rogue Project's Valley Zone. Starting from just below bedrock, the firm reported that it intersected 2.3 g/t gold over 282.9 meters. More >

9,738 g/t Silver, 29 g/t Gold Discovered at Colombia Asset
Source: Stuart McDougall  (8/24/22)
Three newly encountered high-grade areas indicate considerable upside at this precious metals mining project, noted a Research Capital Corp. report. More >

Expert Says Tech Co. Is an 'Attractive Speculative Play'
Source: Clive Maund  (8/23/22)
Expert Clive Maund looks at the six-month chart of TraceSafe Inc. to show how this stock can be both cheap and effective for its buyers. More >

Hedge Fund Doubles Position in Biotech Co.
Source: Streetwise Reports  (8/23/22)
A Canadian hedge fund doubled its stake in a tiny biotech that demonstrated promising results in a study that used a former Sanofi drug called Ifenprodil to treat idiopathic pulmonary fibrosis and chronic cough. Find out the name of the company and why one analyst has given it a 12-month CA$25 target price — a 560% increase from the unit price in its recent placement. More >

Expert Sees Even More 'Good News' From Pharma Co.
Source: Clive Maund  (8/23/22)
Expert Clive Maund reviews the latest news with Algernon Pharmaceuticals Inc., including the recent successful closing of its financing. More >

Mixed Results From Major Gold Companies
Source: Adrian Day  (8/23/22)
Expert Adrian Day reviews the quarterly earnings reports from the remaining precious metals companies on his list, including Wheaton Precious Metals and Franco Nevada, among others. More >

Silver Miner Posts Best Intercept to Date
Source: Streetwise Reports  (8/23/22)
Shares of AbraSilver Resource Corp. traded 13% higher after the company reported assay results from four recently completed holes during this year's Phase 2 drill program at the company's Diablillos silver-gold deposit in Argentina. The firm highlighted results from hole DDH-22-037, which returned 155m of 289 g/t Ag eq, including 30m of 609 g/t Ag eq. More >

Biotech Co. Has Multiple Shots on Goal
Source: Justin Kim  (8/22/22)
This developer of immunotherapies has a robust pipeline, several active clinical programs and, thus, numerous catalysts, noted an Oppenheimer report. More >

Price Target on Cancer Drug Co. Boosted
Source: Joseph Pantginis  (8/22/22)
The price target was increased by 66% to reflect the full potential opportunity of the biopharma's drug candidate for hepatocellular carcinoma, a key driver going forward, noted an H.C. Wainwright & Co. report. More >

Drug Developer Initiates Ph. 3 STGD1 Trial
Source: Streetwise Reports  (8/22/22)
Shares of Belite Bio Inc. traded 19% higher after the company reported it has initiated a pivotal Phase 3 clinical study in the U.S. for its LBS-008 for use in treating Stargardt disease. More >

Tech Wearables Firm Teams with Saudi IT Co in Smart City Buildout
Source: Streetwise Reports  (8/22/22)
A Vancouver-based firm just announced a partnership with the biggest publicly traded IT company in Saudi Arabia as it looks to provide hardware-assisted software solutions for the multi-billion-dollar new Smart City buildout happening in the Middle East. More >

Mining Co. With Four Assets Gains Finance Firm's Attention
Source: Patrick Smith  (8/19/22)
Analyst coverage was initiated on this Canadian mining explorer, which has significant land packages and multimillion ounces of gold in metals-rich areas of Papua New Guinea, noted a Jemini Capital report. More >

Solar Co. Exceeds Revenue Estimates in Q2
Source: Streetwise Reports  (8/19/22)
Shares of Canadian Solar Inc. traded 15% higher yesterday to a new 52-week high after the company reported Q2/22 financial results that highlighted a 62% YoY increase in revenue and raised the ranges of its FY/22 revenue estimates by $500 million. More >

New Drill Data from Gold Project Boost Resources
Source: Pierre Vaillancourt  (8/19/22)
Drill results Troilus Gold Corp. generated in the last four months at this property will be incorporated into the upcoming mineral resource update and prefeasibility study, noted a Haywood Securities report. More >

Biopharma Co. Gains FDA Approval for Oral MDD Drug
Source: Streetwise Reports  (8/19/22)
Shares of Axsome Therapeutics Inc. traded 39% higher after the company reported that the U.S. FDA granted approval for its AUVELITYâ„¢ making it the first oral N-methyl D-aspartate (NMDA) receptor antagonist authorized for treating major depressive disorder in adults. More >

Healthcare Co. Brings Treatment to Canadian Alcohol Addiction Market
Source: Streetwise Reports  (8/18/22)
One healthcare company in the U.K. is bringing its proprietary Ketamine-assisted treatment for Alcohol Use Disorder to Canada. It's the second deal the company has made with a North American clinic operator this week. Find out why this won't be the last one. More >

Green Tech Co. Says Plant's Environmental Permit on Track
Source: Streetwise Reports  (8/17/22)
The government in Ecuador is on track to grant an environmental permit for BacTech Environmental Corp.'s new bioleaching plant in September, the company says. More >

Biotech Co. To Receive 66% Funding From UK Gov.
Source: Clive Maund  (8/17/22)
Expert Clive Maund reviews the latest update with Awakn Life Sciences Corp., including its recent rise in stock volume and the announcement that the company is to receive 66% funding support from the UK government for the development of its ketamine-assisted therapy treatment for alcohol use disorders. More >

Gold Co.'s Target Price Boosted by $5 Per Share
Source: Joe Reagor  (8/17/22)
The new figure takes into account recently determined economics and upside of the world's largest undeveloped gold project along with future precious metals prices, noted a ROTH Capital Partners report. More >